Sotera Health posts 10% revenue growth and $27M net income in Q1 2026, confirms full-year outlook.

Sotera Health reported a 10% increase in net revenues to $280 million and a net income of $27 million in Q1 2026, reversing a loss from the previous year. Adjusted EBITDA rose by 10.5%, driven by strong performances at Sterigenics and Nordion, while Nelson Labs met expectations. The company reaffirmed its 2026 full-year guidance of 5.0%-6.5% revenue growth and 5.5%-7.0% Adjusted EBITDA growth. Additionally, Sotera announced a planned CEO transition and strengthened its board with new independent directors, signaling confidence in its growth trajectory.